1. A randomized controlled trial of single‐class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96‐week results from the FREE study. Issue 2 (4th December 2014) Authors: Sprenger, HG; Langebeek, N; Mulder, PGH; ten Napel, CHH; Vriesendorp, R; Hoepelman, AIM; Legrand, JC; Koopmans, PP; Bravenboer, B; ten Kate, RW; Groeneveld, PHP; Bierman, WFW; van der Werf, TS; Gisolf, EH; Richter, C Journal: HIV medicine Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗